Is there a benefit to using nitroglycerin (glyceryl trinitrate) in the management of angina pectoris (chest pain)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Nitroglycerin is beneficial for chest pain, particularly angina pectoris caused by coronary artery disease, as it provides rapid relief within 1 or 2 minutes by dilating blood vessels and reducing the heart's workload. The typical dose is 0.3-0.4 mg sublingually (under the tongue), which can be repeated every 5 minutes for up to three doses if pain persists, as recommended by the 2024 ESC guidelines for the management of chronic coronary syndromes 1.

Mechanism of Action

Nitroglycerin works by dilating blood vessels, which reduces the heart's workload and improves blood flow to the heart muscle. This vasodilation decreases both preload and afterload, reducing myocardial oxygen demand while simultaneously increasing oxygen supply to the heart. According to the 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines, nitroglycerin should be taken as directed, with a maximum of one dose initially, and emergency services should be called if symptoms persist or worsen 1.

Precautions and Administration

Important precautions include not using nitroglycerin with erectile dysfunction medications like sildenafil due to dangerous blood pressure drops, sitting or lying down when taking it to prevent fainting, and seeking emergency care if chest pain is severe, unusual, or unrelieved after three doses, as this could indicate a heart attack requiring immediate medical attention. The 1999 ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina also highlight the benefits of nitrates in reducing myocardial oxygen demand and improving myocardial perfusion 1.

Ongoing Management

For ongoing angina, longer-acting forms like nitroglycerin patches (0.2-0.8 mg/hour) or oral extended-release tablets (2.5-9 mg) may be prescribed. It is essential to follow the prescribed dosage and administration instructions to maximize the benefits of nitroglycerin while minimizing potential side effects. Overall, nitroglycerin is a valuable medication for the management of angina pectoris, providing rapid relief and improving quality of life for patients with coronary artery disease.

From the FDA Drug Label

The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle. Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds Dilation of postcapillary vessels, including large veins, promotes peripheral pooling of blood, decreases venous return to the heart, and reduces left ventricular end-diastolic pressure (preload) Nitroglycerin also produces arteriolar relaxation, thereby reducing peripheral vascular resistance and arterial pressure (afterload), and dilates large epicardial coronary arteries; however, the extent to which this latter effect contributes to the relief of exertional angina is unclear. Consistent with the symptomatic relief of angina, digital plethysmography indicates that onset of the vasodilatory effect occurs approximately 1 to 3 minutes after sublingual nitroglycerin administration and reaches a maximum by 5 minutes postdose.

Benefits of Nitroglycerin in Angina Management:

  • Relaxation of vascular smooth muscle
  • Dilation of arterial and venous beds
  • Reduction of left ventricular end-diastolic pressure (preload)
  • Reduction of peripheral vascular resistance and arterial pressure (afterload)
  • Dilation of large epicardial coronary arteries
  • Symptomatic relief of angina, with onset of vasodilatory effect within 1-3 minutes and maximum effect by 5 minutes postdose 2

Key Points:

  • Nitroglycerin is effective in relieving angina symptoms
  • The medication works by relaxing vascular smooth muscle and dilating blood vessels
  • It reduces preload and afterload, and dilates coronary arteries
  • The benefits of nitroglycerin in angina management are well-established, with rapid onset of action 2

From the Research

Benefits of Nitroglycerin in Angina Pectoris Management

  • Nitroglycerin is a fast-acting vasodilator commonly used as a first-line agent for angina in the emergency department and to manage chest pain due to acute coronary syndromes 3.
  • The drug is converted to nitric oxide in the body, leading to venodilation at lower dosages and arteriodilation at higher dosages, resulting in both preload and afterload reduction 3.
  • Nitroglycerin has been shown to be effective in relieving chest pain in patients with angina pectoris, including those with acute myocardial infarction and unstable angina 4, 5.
  • The use of intravenous nitroglycerin boluses has been found to be safe and efficacious in patients with chest pain unresponsive to sublingual nitroglycerin therapy 4.
  • Long-acting nitrates, including nitroglycerin, are effective antianginal agents that can be used in clinical medicine, with side effects limited to headache and postural hypotensive symptoms 6.

Administration and Efficacy

  • Nitroglycerin can be administered sublingually, intravenously, or buccally, with each method having its own advantages and disadvantages 3, 7.
  • Intravenous administration of nitroglycerin has been found to be useful in patients with refractory angina, even when refractory to multiple doses of sublingual nitroglycerin 5.
  • Buccal nitroglycerin has been shown to be a safe and well-tolerated alternative to high-dose intravenous nitroglycerin treatment in unstable angina pectoris, with fewer adverse effects 7.
  • The efficacy of nitroglycerin in relieving anginal pain has been found to be similar to that of beta-blockers or calcium channel blockers in the monotherapy of chronic angina 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitroglycerin Use in the Emergency Department: Current Perspectives.

Open access emergency medicine : OAEM, 2022

Research

Bolus i.v. nitroglycerin treatment of ischemic chest pain in the ED.

The American journal of emergency medicine, 1994

Research

Buccal versus intravenous nitroglycerin in unstable angina pectoris.

European journal of clinical pharmacology, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.